![]() |
市場調查報告書
商品編碼
2024763
生物材料市場分析:按類型、應用和地區分類(2026-2034 年)Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2026-2034 |
||||||
2025年全球生醫材料市場規模達1,383億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到3,152億美元,2026年至2034年的複合年成長率為9.29%。除了醫療產業的持續進步外,心血管疾病盛行率的上升也是推動市場成長的主要因素。
3D列印技術的發展
包括3D列印技術在內的新技術的引入,正在改進醫療植入和醫療設備的設計和製造方法。此外,這些技術能夠生產出複雜且針對患者個別情況最佳化的形狀,而這些形狀用傳統方法難以甚至無法實現。因此,這些技術正被廣泛應用於牙科、整形外科、矯正器具等領域,在這些領域,解剖學上的精確性至關重要。這代表了生物材料市場近期最具前景的機會之一。例如,2024年2月,納瓦蒂·馬克斯超級專科醫院在孟買開設了一家醫療3D列印實驗室,以支援高精度手術。
這家開創性的醫療機構與腫瘤科緊密合作,在重組整形外科、腫瘤外科和專業牙科手術領域提供最先進的精準手術,在這些領域,精準度和細緻程度至關重要。此外,利用3D列印技術製造生物材料,以客製化複雜的醫療設備和植入,使其與患者的個別解剖結構相匹配,這項技術的廣泛應用正吸引全球越來越多的關注。
例如,2023年10月,一項研究發表,介紹了卑爾根豪克蘭大學醫院的職業治療師如何利用3D列印和掃描技術來幫助開發個人化手部矯正器具。預計這將減輕疼痛、最大限度地減少功能障礙並提高患者的依從性。此外,3D列印技術能夠將具有不同機械性能的梯度材料融入其中,這也對市場產生了積極影響。例如,2023年10月,贏創推出了用於各種醫療應用的植入級長絲和碳纖維增強PEEK材料。
此外,這些技術正在幫助慢性疾病的治療,預計將在未來幾年提振生物材料市場的整體前景。例如,2023年7月,韓國生命科學與生物技術研究院、韓國機械與材料研究院以及韓國科學技術資訊通訊部下屬某研究所聯合開展的一項研究,宣布了全球首個用於增強自然殺傷(NK)免疫細胞功能的3D生物列印技術。
組織工程創新
組織工程在生物材料研究中發揮著至關重要的作用。作為一種開發生物替代物以維持、修復或改善組織功能的方法,組織工程正迅速普及。例如,2023年6月,OrganaBio宣布推出「NeoPAC」胎盤和臍帶組織,旨在加速再生醫學和細胞療法的發展。此外,OrganaBio同時提供研究級(RUO)和臨床級組織,鼓勵研究人員充分利用出生組織,從而開發創新治療方法以應對多種疾病。
此外,對新型支架(旨在誘導理想的細胞間相互作用以促進新組織形成的材料)日益成長的需求也在推動市場發展。例如,2023年6月,組織工程領域的領先創新者之一3DBioFibR推出了兩款新型膠原蛋白纖維產品:CollaFibR 3D和μCollaFibR支架。這些產品在組織培養和組織工程應用上具有顯著優勢。此外,各機構為建構結構和功能更精確的組織而加大研發投入和科研設施建設,也促進了生物材料市場收入的成長。
例如,2023年1月,美國國家生物醫學影像與生物技術研究所(NIBIB)成立了生物醫學工程技術加速中心(BETA中心),作為一項新的內部研究項目,旨在加速最尖端科技的檢驗、開發和推廣。該中心的研究領域涵蓋生物感測、工程生物學和合成生物學、生物醫學成像、奈米材料和生物材料等多個面向。
拓展傷口敷料的應用
生物材料在先進傷口敷料中的應用日益廣泛,是推動傷口癒合和治療效果顯著的主要成長要素,這些敷料有助於改善包括急性和慢性損傷在內的多種傷口的癒合過程和治療效果。此外,領先企業正在研發用於創傷護理的永續材料。例如,2024年3月,科技部下屬的先進科學技術研究所(IASST)的科學家團隊宣布研發出一種由香蕉纖維製成的環保傷口敷料。
此外,由於這種創新傷口敷料的所有製造材料均取自當地天然材料,因此其生產過程成本低廉、操作簡單且無毒性。同時,人們對生物材料傷口敷料日益成長的興趣也推高了生物材料市場的價格。這些敷料可由多種材料製成,包括發泡體、水凝膠和薄膜,並且通常含有抗菌劑等生物活性物質,以抑制感染並促進組織再生。例如,2022年5月,瑞典醫療設備新創公司Amferia AB向美國展示了其基於雙親性抗菌水凝膠的抗菌材料。
根據2023年6月發表在《生物材料進展雜誌》上的研究顯示,貝爾法斯特女王大學的一個研究團隊設計了一種3D列印繃帶(也稱為支架),這可能是一種治療糖尿病足潰瘍(DFU)的創新治療方法。
The global biomaterials market size reached USD 138.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 315.2 Billion by 2034, exhibiting a growth rate (CAGR) of 9.29% during 2026-2034. Continuous advancements in the healthcare industry, along with the rising prevalence of cardiovascular diseases, are primarily propelling the market.
Development of 3D Printing Technologies
The introduction of novel innovations, including 3D printing technologies, is improving the ways in which medical implants and devices are designed and manufactured. Moreover, they enable the production of patient-specific and complex shapes that are difficult or impossible to achieve with traditional methods. Consequently, these technologies find extensive applications in fields, such as dentistry, orthopedics, prosthetics, etc., where anatomical precision is crucial. This, in turn, is one of the lucrative biomaterials market recent opportunities. For example, in February 2024, Nanavati Max Super Specialty Hospital launched a medical 3D printing laboratory in Mumbai to facilitate high-precision surgeries.
This pioneering facility is closely integrated with oncology to offer state-of-the-art precision surgeries that are required to be performed accurately and carefully in reconstructive orthopedic, oncologic, and specialized dentistry surgeries. Additionally, the widespread integration of 3D printing technology in biomaterials for creating customized and complex medical devices and implants tailored to individual patients' anatomies is further gaining extensive traction across the globe.
For instance, in October 2023, a study was published that assisted the occupational therapists at the Haukeland University Hospital in Bergen to develop personalized hand orthoses by using 3D printing and scanning technologies, which can reduce pain, minimize deterioration, enhance patient compliance, etc. Apart from this, 3D printing allows for the incorporation of gradients of materials with varying mechanical properties, which is also positively influencing the market. For example, in October 2023, Evonik launched implant-grade filaments and carbon-fiber-reinforced PEEK for numerous medical applications.
Furthermore, these technologies assist in the treatment of chronic diseases, which is projected to fuel the overall biomaterials market outlook in the coming years. For example, in July 2023, through joint research with the Korea Research Institute of Bioscience and Biotechnology, the Korea Institute of Machinery and Materials, and the institute under the jurisdiction of the Ministry of Science and ICT launched the world's first 3D bioprinting technology that enhances the function of natural killer (NK) immune cells.
Innovations in Tissue Engineering
Tissue engineering plays an important role in biomaterials research. It is gaining immense popularity for developing biological substitutes to maintain, restore, or improve tissue function. For example, in June 2023, OrganaBio announced the introduction of NeoPAC placenta and umbilical cord tissues that are specifically designed to accelerate the progress of regenerative medicine and cell therapy. Moreover, by providing both Research Use Only (RUO) and clinical-grade tissues, OrganaBio encourages researchers to tap into the potential of birth tissues, thereby enabling the development of innovative therapies to address numerous medical conditions.
Apart from this, the rising demand for novel scaffolds that are materials engineered to cause desirable cellular interactions to facilitate the formation of new tissues is also elevating the market. For instance, in June 2023, 3DBioFibR, one of the leading innovators in tissue engineering, released two new collagen fiber products, namely CollaFibR 3D and μCollaFibR scaffold. These variants offer significant benefits for tissue culture and tissue engineering applications. Additionally, the elevating investments in R&D activities and research facilities by various organizations to enable the engineering of more structurally and functionally accurate tissues are contributing to the biomaterials market revenue.
For example, in January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Center for Biomedical Engineering Technology Acceleration (BETA Center), a new intramural research program to accelerate the validation, development, and dissemination of cutting-edge technologies. The center focuses on several areas, such as biosensing, engineered and synthetic biology, biomedical imaging, nanomaterials and biomaterials, etc.
Growing Applications in Wound Dressings
The rising adoption of biomaterials in advanced wound dressings, as they help in improving the healing process and outcomes for numerous types of wounds, including acute and chronic injuries, is acting as a significant growth-inducing factor. Besides this, key players are developing sustainable materials for wound care. For example, in March 2024, a team of scientists at the Institute of Advanced Study in Science and Technology (IASST), under the Department of Science and Technology, introduced an eco-friendly wound dressing material made using banana fibers.
Moreover, all the materials utilized in creating this innovative dressing material are locally available and natural, making the manufacturing process cost-effective, simple, and non-toxic. Apart from this, the increasing inclination towards bio-material-based wound dressings is elevating the biomaterials market prices. They can be produced from various materials, including foams, hydrogels, films, etc., that are often imbued with bioactive substances like antimicrobial agents to reduce infection and promote tissue regeneration. For instance, in May 2022, Amferia AB, a Swedish medical device startup, was granted a foundational patent by the U.S.
Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. In line with this, in June 2023, according to the findings published in the Journal of Biomaterials Advances, a team of researchers from Queen's University of Belfast designed a 3D printed bandage, also called a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs).
The research provides an analysis of the key trends in each segment of the market, along with the biomaterials market forecast at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on the type and application.
Currently, metallic biomaterial accounts for the largest market share
The growth in this segmentation is driven due to exceptional strength, optimal durability, and enhanced biocompatibility exhibited by metallic biomaterials. Consequently, they find extensive load-bearing applications, including dental implants, orthopedic implants, cardiovascular devices, etc. For instance, in April 2024, Boston Micro Fabrication (BMF) announced the U.S. Food and Drug Administration (FDA) clearance for its innovative UltraThineer material. Moreover, several metals, such as stainless steel, titanium, cobalt-chromium alloys, etc., are widely used, owing to their superior mechanical properties that ensure longevity and resilience under the stress of bodily movements.
For example, in January 2022, according to the journal Colloids and Surfaces A, researchers efficiently modified a TC26 alloy with nanoporous TiO2 to enhance the osseointegration and bioactivity of artificial implants. In addition to this, in June 2023, Technopolis Moscow SEZ announced the production of titanium implants. As a result, the increasing product applications will continue to drive the metallic biomaterials market demand in the coming years.
Durable ceramic, metallic, and polymer-based materials are essential for joint replacements and bone repair. Moreover, they are adopted in the manufacturing of reconstructive devices that require high compatibility and strength with oral tissues. Apart from this, key areas, including neurology and cardiology, require biomaterials for neural implants, brain-machine interfaces, stents, pacemakers, etc.
For instance, in February 2022, Researchers at the Lundquist Institute for Biomedical Innovation, Penn State, and the University of California Los Angeles developed novel biomaterials to promote new blood vessels and target post-stroke immune responses. According to the biomaterials market statistics, the other category encompasses additional applications like drug delivery systems and ophthalmology, where biomaterials offer tailored solutions for implants and controlled medication release, respectively.
North America currently dominates the global market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest biomaterials market share.
The favorable regulatory environment in North America, particularly the role of the U.S. Food and Drug Administration (FDA), which supports the rapid approval and development of new biomaterials and medical devices, is fueling the regional market. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which is based on a different biomaterial Zfuze, a combination of titanium and poly-ether-ether-ketone. Additionally, in October 2023, Dimension Inx, one of the biomaterials platform companies, announced the FDA approval of CMFlex, the first 3D-printed regenerative bone graft product.
Moreover, the growing number of ambulatory surgical centers (ASCs) that perform spinal surgeries is acting as another significant growth-inducing factor. For instance, in February 2023, according to Becker's Healthcare data showcased that more than 183 ASCs in the United States perform minimally invasive spine surgery (MISS). Apart from this, the inflating popularity of cosmetic surgeries is further stimulating the regional market. In addition, the launch of initiatives undertaken by several public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, which provide assistance pertaining to biomaterials usage, is expected to fuel the market in North America over the forecasted period.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major biomaterials market companies have also been provided. Some of the key players in the market include: